86 rules to prepare for the third batch of collection! The largest number of 153 enterprises involved was included in 9 varieties.

Text . . . Microyang Today (July 21), Shanghai Sunshine Pharmaceutical Procurement Network announced 86 standard drugs and collected relevant information to prepare for the third batch of collection, this 86 standards (involving 56 varieties) in line with the previous provinces reported procurement volume list.
through the previous round of national collection of the discovery, for the collection of drugs requirements, the scope of the declaration of enterprises are consistent with the previous.
reference agents for the evaluation of the quality and efficacy consistency of generic drugs issued by the original research drug and the State Drug Administration.
generic drugs that are evaluated for quality and efficacy of generic drugs through the State Drug Administration.
, in accordance with the "State Food and Drug Administration on the release of chemical drug registration classification reform work programme" (No. 51 2016), according to the new registration of chemical drugs approved generic drugs.
drugs included in the China Listed Drug List.
and for the collection of information for this document, is the last batch of national collection documents, part of the enterprise declaration materials, the specific information is as follows: production enterprises, drug listing license holders, overseas production enterprises in the Chinese mainland set up or designated and can bear the corresponding legal responsibilities of the representative institutions or corporate legal persons (including enterprise names, unified social credit code, contacts, authorizations, etc.).
supporting materials (including drug registration approvals, supplementary registration approvals, instructions, etc.) that meet the requirements of the drug.
production capacity and instructions for the production of raw materials and pharmaceuticals.
the second batch of national collection is the state first to give the collection list and detailed tender documents, and then meet the requirements of the enterprise preparation information, in the prescribed time to submit information is immediately followed by the bid;
first submit information and then produce a formal collection list, which also means that the third batch of collection officially started, looking back at the past collection process can be found, from the symposium to the official documents published about 20 days or so;
this process is slightly different from the past, but we predict it is likely that a third batch of collection documents will likely be issued by August 10th, with the winning results due at the end of August.
Insight collating the key nodes of the past collection According to insight database statistics, as of July 21, 86 companies that meet the conditions for collection involved a total of 153 enterprises, including China Biopharmaceuticals, Shanghai Pharmaceutical Group, Shi Pharma Group, Yangzijiang, Haussen, Hengrui, etc. (here Insight database according to the parent enterprise statistics).
this variety, involving more foreign-funded enterprises than before, according to incomplete statistics a total of 21 foreign enterprises, including selected more varieties of enterprises are Pfizer, Mercado, AstraZeneca and other multinational pharmaceutical giants.
of course, the above statistics are based on the 86 product rules published so now, which will ultimately be based on the official list. note
: The original text has a limitation.